Search research articles
Contact Us
Filters
Showing results (121-130 of 196) with videos related to
Page
of 20
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1994
2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine
M A Dimopoulos, D M Weber, H Kantarjian, et al.
Bone Marrow Transplantation
|
June 1, 2004
Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma
R Alexanian, D Weber, K Delasalle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1995
Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factors
M A Dimopoulos, D Weber, K B Delasalle, et al.
The British Journal of Radiology
|
November 1, 1988
Macroglobulinaemic lymphoma presenting with perirenal masses
J G Lorigan, C L David, A Shirkhoda, et al.
Blood
|
August 1, 1985
Prognostic implications of tumor cell DNA and RNA content in multiple myeloma
B Barlogie, R Alexanian, D Dixon, et al.
Cancer
|
December 1, 1977
Combination therapy for multiple myeloma
R Alexanian, S Salmon, J Bonnet, et al.
Stem Cells (Dayton, Ohio)
|
August 1, 1995
Myeloablative therapy for primary resistant multiple myeloma
R Alexanian, M A Dimopoulos, K B Delasalle, et al.
The American Journal of Medicine
|
January 1, 1993
Risk of disease progression in asymptomatic multiple myeloma
M A Dimopoulos, A Moulopoulos, T Smith, et al.
Cytotherapy
|
August 26, 2010
Transplantation of human glial-restricted neural precursors into injured spinal cord promotes functional and sensory recovery without causing allodynia
Arshak R Alexanian, Clive N Svendsen, Maria J Crowe, et al.
Cancer
|
April 15, 1981
Chemoimmunotherapy for multiple myeloma
R Alexanian, S Salmon, J Gutterman, et al.
Page
of 20
Search research articles
Search
Showing results (121-130 of 196) with videos related to
Sort By:
Page
of 20
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 1, 1994
2Chlorodeoxyadenosine therapy of patients with Waldenström macroglobulinemia previously treated with fludarabine
M A Dimopoulos, D M Weber, H Kantarjian, et al.
Bone Marrow Transplantation
|
June 1, 2004
Clinical outcomes with intensive therapy for patients with primary resistant multiple myeloma
R Alexanian, D Weber, K Delasalle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 1, 1995
Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factors
M A Dimopoulos, D Weber, K B Delasalle, et al.
The British Journal of Radiology
|
November 1, 1988
Macroglobulinaemic lymphoma presenting with perirenal masses
J G Lorigan, C L David, A Shirkhoda, et al.
Blood
|
August 1, 1985
Prognostic implications of tumor cell DNA and RNA content in multiple myeloma
B Barlogie, R Alexanian, D Dixon, et al.
Cancer
|
December 1, 1977
Combination therapy for multiple myeloma
R Alexanian, S Salmon, J Bonnet, et al.
Stem Cells (Dayton, Ohio)
|
August 1, 1995
Myeloablative therapy for primary resistant multiple myeloma
R Alexanian, M A Dimopoulos, K B Delasalle, et al.
The American Journal of Medicine
|
January 1, 1993
Risk of disease progression in asymptomatic multiple myeloma
M A Dimopoulos, A Moulopoulos, T Smith, et al.
Cytotherapy
|
August 26, 2010
Transplantation of human glial-restricted neural precursors into injured spinal cord promotes functional and sensory recovery without causing allodynia
Arshak R Alexanian, Clive N Svendsen, Maria J Crowe, et al.
Cancer
|
April 15, 1981
Chemoimmunotherapy for multiple myeloma
R Alexanian, S Salmon, J Gutterman, et al.
Page
of 20